Information for:

Resources

Andrew Mellor

Andrew Mellor

Academic Appointment(s)

Emeritus Faculty

  • (706) 721-8735
  • (706) 721-8732
  • CN 4151

Education

  • MA, Biochemistry University of Cambridge, 1979

  • Ph.D., Biochemistry Univ of London, 1979

  • BA, Biochemistry University of Cambridge, 1976

Courses Taught Most Recent Academic Year

  • MOLM 9210

    Invest of a Problem

  • MOLM 9300

    Research

  • COGS 8030

    Experimental Therapeutics

  • COGS 8240

    Intro to Imm/Inf Disease

Scholarship

Selected Recent Publications

  • Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells, 2015
    Journal Article, Academic Journal
  • STING, nanoparticles, autoimmune disease and cancer: A novel paradigm for immunotherapy?, 2015
    Journal Article, Academic Journal
  • β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin a metabolism in dendritic cells, 2015
    Journal Article, Academic Journal
  • Activation of the STING adaptor attenuates experimental autoimmune encephalitis, 2014
    Journal Article, Academic Journal
  • GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathology, 2014
    Journal Article, Academic Journal